4
Changes in Ownership
Oncotelic Therapeutics, Inc. Filed Acc 0001181431-14-020173
Options or other derivatives
- President and CEO acquired 150,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| CHAPLIN DAVID President and CEO | 2014-05-15 | Grant or award · Employee Stock Option (Right to Buy) | +150,000 | 150,000 | D: show line 1 in the form |
Loading xslF345X03/rrd409733.xml…